English 
Spanish 
Arabic 
Chinese 
French 
Body contouring · DBL™ patient guide
DBL™ is the name used by Dr Ducu Clinics for a doctor-led buttock contouring procedure in which hyaluronic acid dermal filler is placed with a cannula according to an individual treatment plan. It may be considered for selected concerns involving volume, projection, asymmetry or contour, but it is a higher-risk injectable procedure—not a routine beauty treatment—and a consultation does not automatically mean that treatment should proceed.
The essential idea
Assessment comes before product volume or shape labels. The same request—more roundness, less visible hip dips or improved symmetry—can arise from different combinations of bone structure, muscle, fat distribution, skin quality, prior surgery and existing filler. DBL™ can add or redistribute apparent volume in selected areas; it cannot change the pelvis, strengthen muscle, remove a substantial skin excess or guarantee symmetry.
What DBL™ is—and what the name does not mean
Dr Ducu Clinics describes DBL™ / Ducu Butt Lift as a minimally invasive buttock-contouring technique developed by Dr Ducu. Hyaluronic acid filler is placed through cannula entry points in planned tissue layers to support selected changes in shape, volume, projection or symmetry. The official procedure page lists an indicative treatment time of approximately two hours, while recognising that plans and recovery vary.
The words “butt lift” can be misleading if read literally. Injectable filler adds volume; it does not surgically lift and secure tissues. Any lifted appearance is an optical contour effect created by where volume is added and how it relates to the person’s existing anatomy.
“Non-surgical BBL” is also a market description used to distinguish filler treatment from surgical fat transfer. In England, however, official government material notes that the Care Quality Commission considers large-volume filler inserted into the buttocks by a healthcare professional to be a surgical procedure and therefore a regulated activity. UK professional guidance likewise treats buttock augmentation with dermal filler as a high-risk procedure requiring appropriately qualified medical practice. The absence of liposuction or a large incision should not be confused with the absence of serious risk.
DBL™ and a surgical Brazilian Butt Lift are not interchangeable. Surgical BBL involves harvesting and transferring a person’s own fat; DBL™ uses an injectable medical device. The procedures have different eligibility criteria, volume capacity, recovery, durability and complications.
Why assessment must come before a treatment plan
A photograph or shape category cannot establish suitability. The gluteal region is three-dimensional, weight-bearing and anatomically complex. Planning must account for the relationship between the buttocks, hips, waist and thighs, as well as the condition of the tissues beneath the visible surface.
Layer 01
Skeletal frame
Pelvic width and bony proportions influence the silhouette but cannot be changed by filler.
Layer 02
Muscle and fat
Gluteal muscle and regional fat distribution determine baseline projection and cannot be inferred from body weight alone.
Layer 03
Skin envelope
Elasticity, laxity, dimpling, scars and stretch marks affect what added volume can—and cannot—achieve.
Layer 04
Previous treatment
Prior filler, fat transfer, liposuction, implants, infection or scarring can alter planes, circulation and risk.
The medical assessment should review health conditions, allergies, medicines and supplements, clotting history, previous reactions, infection risk, pregnancy or breastfeeding status, recent illness and the person’s ability to follow aftercare. Prescribed anticoagulants or antiplatelet medicines must not be stopped without advice from the prescribing clinician and treating doctor.
The clinician must then decide whether filler is appropriate at all, not simply how many millilitres to use. A request for a very large change, substantial skin removal or correction of a complication may point to a different pathway or no elective treatment.
What DBL™ may address in selected patients
The procedure is not defined by one universal buttock shape. Treatment should be planned around a specific, assessable contour concern and a realistic scale of change.
| Concern | What filler may contribute | What must be established first |
|---|---|---|
| Limited volume or projection | Add selected volume to alter the profile or upper and lateral contour. | Whether the requested scale is achievable without excessive product or distorted proportions. |
| Hip dips | Soften a selected transition between the hip and buttock. | How much of the indentation reflects normal bone and muscle anatomy. |
| Asymmetry | Add differential volume to selected areas. | Whether the asymmetry arises from volume, pelvis, posture, muscle, scarring or another cause. |
| Post-procedure contour irregularity | Camouflage a selected depression or transition where tissues are suitable. | What was previously performed, whether filler remains and whether there is fibrosis, infection or implant-related pathology. |
| Selected dimpling | Alter the appearance of an appropriate depression within a broader plan. | Whether tethering, cellulite, laxity or volume loss is the main mechanism. |
The official Dr Ducu Clinics page also notes that DBL™ may be considered for selected concerns after liposuction, surgical BBL or buttock implants. “May be considered” is important: previous surgery makes diagnosis and planning more complex and does not mean that filler is always an appropriate correction.
What filler cannot correct
A safe consultation includes a clear “cannot” list. Added filler can change contour, but it does not convert every anatomical or surgical problem into an injectable indication.
Cannot change
Bone or muscle structure
Filler cannot narrow the pelvis, alter skeletal proportions or replace gluteal muscle development.
Cannot remove
Substantial loose skin
Adding volume may not correct marked laxity and can make an area larger without resolving the skin envelope.
Cannot guarantee
Perfect symmetry
Baseline asymmetry, posture, movement and unequal tissue response can remain after treatment.
Cannot treat
Active complications blindly
Pain, infection, collections, implant problems or unknown previous products need diagnosis—not camouflage.
DBL™ is not a weight-loss treatment and cannot determine how weight will be gained or lost later. It also cannot promise a celebrity reference shape, because external examples do not share the patient’s frame, tissue quality or previous procedures.
Results are not permanent. Hyaluronic acid filler is gradually broken down, although the rate is variable. Maintenance adds further cost, exposure and procedural risk and should be treated as a new clinical decision rather than an automatic appointment.
Suitability and reasons to pause or decline treatment
A potentially suitable adult has a defined contour goal that filler can reasonably address, understands the scale and temporary nature of the result, accepts the risks and can follow recovery instructions. Suitability is not established by age, BMI or desire alone.
| Finding | Why it matters | Possible response |
|---|---|---|
| Active skin or systemic infection | Injection can introduce or spread infection around a large implanted volume. | Do not proceed; investigate and treat appropriately. |
| Unknown previous filler | Product identity, location and tissue reaction may be uncertain. | Obtain records and consider examination or imaging before planning. |
| Recent surgery or unresolved swelling | The contour may not be stable and complications can be obscured. | Allow appropriate healing and seek the operating team’s information. |
| Bleeding, clotting or healing concerns | They may increase procedural or recovery risk. | Obtain relevant medical advice and modify or decline the plan. |
| Expectation exceeds safe filler correction | Escalating volume to chase an unsuitable goal can increase risk. | Discuss alternatives or no procedure. |
Pregnancy or breastfeeding, relevant allergy or hypersensitivity, active inflammatory disease, unstable health, inability to consent or unrealistic expectations may also require deferral or make elective treatment inappropriate. This is not a complete contraindication list; only the treating medical team can assess an individual case.
From consultation to review
The pathway should allow a voluntary, informed decision without time pressure. GMC guidance requires doctors offering cosmetic interventions to discuss benefits, risks and outcomes clearly, obtain consent themselves and give patients time to reflect.
Stage 01
Medical assessment
Health, medicines, previous procedures, tissue condition, proportions and the actual concern are reviewed.
Stage 02
Plan and consent
Target zones, estimated volume, product, alternatives, limits, material risks, cost and aftercare are discussed.
Stage 03
Cannula placement
After marking and local anaesthetic where appropriate, filler is placed in the planned layer through selected entry points.
Stage 04
Aftercare and review
Healing, contour and any concern are reviewed before deciding whether observation, treatment or a later adjustment is appropriate.
The clinic notes that ultrasound may be used at the beginning of the procedure to assess anatomy, vessels, previous filler or anatomical variation. Ultrasound can support assessment and planning, but it does not remove the inherent risks of a large-volume injectable procedure.
The estimated amount should follow the anatomy and treatment objective. A millilitre target chosen before assessment reverses the clinical order and can encourage unnecessary volume. Multiple sessions may be more appropriate than pursuing the entire change at once. Our article on local anaesthesia and DBL™ buttock contouring explains what patients may feel and what is discussed before treatment.
Recovery and how the result settles
Swelling, bruising, redness, tenderness, discomfort, needle or cannula marks, numbness and temporary asymmetry may occur. Some patients return to routine activities quickly, but “quickly” is not the same as no recovery or no restrictions.
| Phase | What may occur | Decision point |
|---|---|---|
| Immediately afterwards | Added volume is visible, but swelling and local tissue response affect shape. | Do not judge final symmetry or request an immediate top-up from the first appearance. |
| First days | Bruising, tenderness, tightness or unequal swelling may be noticeable. | Follow the individual activity, hygiene and positioning instructions. |
| Following weeks | Swelling reduces and the contour begins to settle. | Persistent pain, heat, redness, discharge, skin change or worsening swelling needs clinical review. |
| Planned review | The treated contour is compared with the agreed objective after appropriate settling. | A top-up is optional and must be justified by a fresh assessment. |
The official clinic instructions take priority over general online advice. Do not massage or manipulate the area unless the treating clinician specifically advises it. Ask in advance how sitting, sleeping, washing, travel, work and exercise should be managed for the actual treatment plan.
Risks, complications and the limits of evidence
Common short-term effects can include swelling, bruising, redness, tenderness, discomfort, entry-point marks and temporary asymmetry. Less common or serious complications include infection, abscess or collection, migration, nodules, granuloma, prolonged inflammation, bleeding, delayed healing, scarring, skin necrosis, contour irregularity, hypersensitivity, vascular injury or occlusion, embolic events, hospitalisation, surgical intervention and an unsatisfactory result.
A 2023 systematic review of hyaluronic acid gluteal augmentation found only ten eligible articles involving 168 patients. It reported both minor events and serious complications and called for better research. Those data do not establish the personal risk of DBL™, nor should evidence for one filler, volume or technique be transferred automatically to another. The long-term effects of large-volume body filler remain incompletely characterised.
Symptoms that need urgent assessment
Contact the treating team urgently for severe or increasing pain, rapidly worsening or one-sided swelling, skin that becomes pale, mottled, dusky or blistered, spreading redness, heat, pus, fever, persistent bleeding, a new open wound, marked weakness or numbness, or any sudden change identified in the aftercare plan.
Breathlessness, chest pain, coughing blood, collapse, confusion, stroke-like symptoms or a severe allergic reaction are medical emergencies. Call 999 in the UK. Do not wait for a routine clinic reply.
Being able to dissolve some hyaluronic acid fillers does not make the procedure reversible in the ordinary sense. Dissolution may be incomplete, does not undo tissue injury or infection and carries its own risks. Emergency and corrective care must therefore be planned before treatment, not improvised after a complication.
Choosing a provider in London: questions beyond before-and-after images
UK guidance treats buttock augmentation with filler as a high-risk intervention. Ask who performs the procedure, whether they are registered with the General Medical Council, what additional training and ongoing competence they have, where treatment takes place, and whether the provider is registered for the relevant regulated activity.
The CQC register lists DrDucu London at 199 Gloucester Terrace as an independent hospital run by NKD Medical Limited, registered for surgical procedures, diagnostic and screening procedures, and treatment of disease, disorder or injury. It was registered on 2 April 2026 and was shown as not yet inspected when this article was prepared. Registration must not be presented as an inspection rating or endorsement.
Ask the clinic to explain:
- the exact product, its regulatory status, intended use and why it is proposed;
- the intended tissue plane, planned volume and reason for each target zone;
- the clinician’s experience with buttock augmentation and complication management;
- how previous filler, surgery or implants will be assessed;
- what emergency equipment, medicines, imaging and transfer arrangements are available;
- who provides out-of-hours advice and face-to-face review;
- what corrective care may involve and who pays if additional treatment is required.
Frequently asked questions
What is DBL™ buttock contouring?
Is DBL™ the same as a surgical Brazilian Butt Lift?
Why is it called non-surgical if UK guidance treats it as surgical?
Can DBL™ fill hip dips?
Can it make the buttocks much larger?
Can DBL™ correct asymmetry?
Can it repair a previous BBL, liposuction or implant problem?
How much filler will I need?
Is ultrasound used for DBL™?
How long does the procedure take?
Can I sit normally after DBL™?
When is the final result visible?
How long does DBL™ last?
Can hyaluronic acid buttock filler be dissolved?
What should I bring to the consultation?
Individual medical assessment
Define the contour concern before deciding on treatment
A consultation can review anatomy, previous procedures, medical history, realistic scale of change, alternatives, recovery and material risks. It does not commit you to DBL™.
Medical and regulatory sources
- Dr Ducu Clinics: Non-Surgical BBL / DBL™ in London
- Effectiveness and Role of Using Hyaluronic Acid Injections for Gluteal Augmentation: systematic review
- Department of Health and Social Care: licensing of non-surgical cosmetic procedures in England—consultation response
- JCCP and partner bodies: Buttock augmentation and other body contouring procedures
- Care Quality Commission: DrDucu London, Gloucester Terrace
- NHS: Choosing who will do your cosmetic procedure
- GMC: Guidance for doctors who offer cosmetic interventions
- Botulinum Toxin and Cosmetic Fillers (Children) Act 2021
- ASA/CAP: Guidance on marketing cosmetic interventions